Klotho and Postmenopausal Hormone Replacement therapy in Women with Chronic Kidney Disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Kidney function is highly susceptible to age-related changes, with chronic kidney disease (CKD) serving as an important cause of morbidity and mortality in older patients. The prevalence of CKD in Korea is higher among the elderly, relative to the general population, with the most significant increases seen following the onset of menopause. Under normal conditions, estrogen attenuates renal superoxide production and protects the kidney from oxidative damage. As estrogen levels are known to decrease by as much as 80% during menopause, this represents a significant risk for older women. Postmenopausal hormone replacement therapy (HRT) modulates the renin-angiotensin system, thereby reducing the progressive deterioration of renal function. Use of estrogen-based HRT has been shown to ameliorate renal function in postmenopausal women, and delay CKD progression. Renal expression of klotho, an important suppressor of aging, is markedly decreased in CKD patients, making it a promising candidate for use as a prognostic biomarker in CKD. Here, we review the key links between renal function, sex, age, and estrogen levels during menopause, and discuss the use of postmenopausal HRT in CKD attenuation.
Abstract
Kidney function is highly susceptible to age-related changes, with chronic kidney disease (CKD) serving as an important cause of morbidity and mortality in older patients. The prevalence of CKD in Korea is higher among the elderly, relative to the general population, with the most significant increases seen following the onset of menopause. Under normal conditions, estrogen attenuates renal superoxide production and protects the kidney from oxidative damage. As estrogen levels are known to decrease by as much as 80% during menopause, this represents a significant risk for older women. Postmenopausal hormone replacement therapy (HRT) modulates the renin-angiotensin system, thereby reducing the progressive deterioration of renal function. Use of estrogen-based HRT has been shown to ameliorate renal function in postmenopausal women, and delay CKD progression. Renal expression of klotho, an important suppressor of aging, is markedly decreased in CKD patients, making it a promising candidate for use as a prognostic biomarker in CKD. Here, we review the key links between renal function, sex, age, and estrogen levels during menopause, and discuss the use of postmenopausal HRT in CKD attenuation.
참고문헌 (38)
- 박지인, "Prevalence of Chronic Kidney Disease in Korea: the Korean National Health and Nutritional Examination Survey 2011-2013", Journal of Korean Medical Science, 31(6), pp.915~923 (2016), 대한의학회
- Yu M, "Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey", Nephrol Dial Transplant, 25, pp.469~477 (2010)
- Ahmed SB, "Sex hormones in women with kidney disease", Nephrol Dial Transplant, 31, pp.1787~1795 (2016)
- Mencke R, "Effects of Klotho on fibrosis and cancer: a renal focus on mechanisms and therapeutic strategies", Adv Drug Deliv Rev, 121, pp.85~100 (2017)
- 김성권, "The Prevalence of Chronic Kidney Disease (CKD) and the Associated Factors to CKD in Urban Korea: A Population-based Cross-sectional Epidemiologic Study", Journal of Korean Medical Science, 24, pp.11~21 (2009), 대한의학회
- Stenvinkel P, "Chronic kidney disease: a clinical model of premature aging", Am J Kidney Dis, 62, pp.339~351 (2013)
- Weinstein JR, "The aging kidney: physiological changes", Adv Chronic Kidney Dis, 17, pp.302~307 (2010)
- Davies DF, "Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males", J Clin Invest, 29, pp.496~507 (1950)
- Rowe JW, "The effect of age on creatinine clearance in men: a crosssectional and longitudinal study", J Gerontol, 31, pp.155~163 (1976)
- Hollenberg NK, "Senescence and the renal vasculature in normal man", Circ Res, 34, pp.309~316 (1974)
- Pitts TO, "Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure", J Clin Endocrinol Metab, 67, pp.876~881 (1988)
- Lips P, "Vitamin D and osteoporosis in chronic kidney disease", J Nephrol, 30, pp.671~675 (2017)
- 윤보현, "Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women", 대한폐경학회지, 22(3), pp.167~173 (2016), 대한폐경학회
- Gipson D, "Principles of dialysis: special issues in women", Semin Nephrol, 19, pp.140~147 (1999)
- Weisinger JR, "Outcomes associated with hypogonadism in women with chronic kidney disease", Adv Chronic Kidney Dis, 11, pp.361~370 (2004)
- Cobo G, "Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis", Clin Sci (Lond), 130, pp.1147~1163 (2016)
- Neugarten J, "Effect of gender on the progression of nondiabetic renal disease: a meta-analysis", J Am Soc Nephrol, 11, pp.319~329 (2000)
- Luksha L, "Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal disease", PLoS One, 7, pp.e36056~ (2012)
- Schmidt RJ, "Total nitric oxide production is low in patients with chronic renal disease", Kidney Int, 58, pp.1261~1266 (2000)
- Schmidt RJ, "Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis", Am J Physiol, 276, pp.F794~F797 (1999)
- Ji H, "Sex differences in renal injury and nitric oxide production in renal wrap hypertension", Am J Physiol Heart Circ Physiol, 288, pp.H43~H47 (2005)
- Forte P, "Evidence for a difference in nitric oxide biosynthesis between healthy women and men", Hypertension, 32, pp.730~734 (1998)
- Neugarten J, "Sex hormones and renal nitric oxide synthases", J Am Soc Nephrol, 8, pp.1240~1246 (1997)
- Xiao S, "Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth", Hypertension, 37, pp.645~650 (2001)
- Ji H, "Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production", Gend Med, 4, pp.56~71 (2007)
- Cohen AM, "Male sex hormone and nephropathy in Cohen diabetic rat. (Genetically selected sucrose fed)", Diabete Metab, 10, pp.199~205 (1984)
- Lim VS, "Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation", Ann Intern Med, 93, pp.21~27 (1980)
- Ramesh S, "Sex hormone status in women with chronic kidney disease: survey of nephrologists' and renal allied health care providers' perceptions", Can J Kidney Health Dis, 4 (2017)
- 김준모, "Postmenopausal Hypertension and Sodium Sensitivity", 대한폐경학회지, 20(1), pp.1~6 (2014), 대한폐경학회
- Monster TB, "Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria", Arch Intern Med, 161, pp.2000~2005 (2001)
- Schopick EL, "Post-menopausal hormone use and albuminuria", Nephrol Dial Transplant, 24, pp.3739~3744 (2009)
- Fung MM, "A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study", Menopause, 18, pp.629~637 (2011)
- Hu MC, "Klotho deficiency causes vascular calcification in chronic kidney disease", J Am Soc Nephrol, 22, pp.124~136 (2011)
- Koh N, "Severely reduced production of klotho in human chronic renal failure kidney", Biochem Biophys Res Commun, 280, pp.1015~1020 (2001)
- Hu MC, "Klotho and chronic kidney disease", Contrib Nephrol, 180, pp.47~63 (2013)
- Lim JH, "Age-associated molecular changes in the kidney in aged mice", Oxid Med Cell Longev, 2012, pp.171383~ (2012)
- Hsu SC, "Testosterone increases renal anti-aging klotho gene expression via the androgen receptor-mediated pathway", Biochem J, 464, pp.221~229 (2014)
- Oz OK, "Aromatase deficiency causes altered expression of molecules critical for calcium reabsorption in the kidneys of female mice *", J Bone Miner Res, 22, pp.1893~1902 (2007)